Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Altered dopamine activity after recovery from restricting-type anorexia nervosa.

Kaye WH, Frank GK, McConaha C.

Neuropsychopharmacology. 1999 Oct;21(4):503-6.

2.

Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa.

Kaye WH, Greeno CG, Moss H, Fernstrom J, Fernstrom M, Lilenfeld LR, Weltzin TE, Mann JJ.

Arch Gen Psychiatry. 1998 Oct;55(10):927-35.

PMID:
9783564
3.

Reduced gastrin releasing peptide in cerebrospinal fluid after recovery from bulimia nervosa.

Frank GK, Kaye WH, Ladenheim EE, McConaha C.

Appetite. 2001 Aug;37(1):9-14.

PMID:
11562153
4.

CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype.

Frank GK, Kaye WH, Altemus M, Greeno CG.

Biol Psychiatry. 2000 Aug 15;48(4):315-8.

PMID:
10960163
5.

Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.

Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, Mathis CA, Drevets WC, Wagner A, Hoge J, Ziolko SK, McConaha CW, Kaye WH.

Arch Gen Psychiatry. 2005 Sep;62(9):1032-41.

PMID:
16143735
6.

Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.

Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L, McConaha CW, Henry SE, Brooks-Achenbach S, Barbarich NC, Kaye WH.

Neuropsychopharmacology. 2004 Jun;29(6):1143-55.

7.

Normal brain tissue volumes after long-term recovery in anorexia and bulimia nervosa.

Wagner A, Greer P, Bailer UF, Frank GK, Henry SE, Putnam K, Meltzer CC, Ziolko SK, Hoge J, McConaha C, Kaye WH.

Biol Psychiatry. 2006 Feb 1;59(3):291-3. Epub 2005 Sep 1.

PMID:
16139807
8.

CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.

Demitrack MA, Lesem MD, Listwak SJ, Brandt HA, Jimerson DC, Gold PW.

Am J Psychiatry. 1990 Jul;147(7):882-6.

PMID:
2356873
9.

Personality characteristics of women before and after recovery from an eating disorder.

Klump KL, Strober M, Bulik CM, Thornton L, Johnson C, Devlin B, Fichter MM, Halmi KA, Kaplan AS, Woodside DB, Crow S, Mitchell J, Rotondo A, Keel PK, Berrettini WH, Plotnicov K, Pollice C, Lilenfeld LR, Kaye WH.

Psychol Med. 2004 Nov;34(8):1407-18.

PMID:
15724872
10.

Could reduced cerebrospinal fluid (csf) galanin contribute to restricted eating in anorexia nervosa?

Frank GK, Kaye WH, Sahu A, Fernstrom J, McConaha C.

Neuropsychopharmacology. 2001 Jun;24(6):706-9.

11.

Neurotransmitter and imaging studies in anorexia nervosa: new targets for treatment.

Barbarich NC, Kaye WH, Jimerson D.

Curr Drug Targets CNS Neurol Disord. 2003 Feb;2(1):61-72. Review.

PMID:
12769813
12.

Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type.

Eddy KT, Lawson EA, Meade C, Meenaghan E, Horton SE, Misra M, Klibanski A, Miller KK.

J Clin Psychiatry. 2015 Jan;76(1):19-24. doi: 10.4088/JCP.13m08753.

13.

Altered reward processing in women recovered from anorexia nervosa.

Wagner A, Aizenstein H, Venkatraman VK, Fudge J, May JC, Mazurkewicz L, Frank GK, Bailer UF, Fischer L, Nguyen V, Carter C, Putnam K, Kaye WH.

Am J Psychiatry. 2007 Dec;164(12):1842-9.

PMID:
18056239
14.

Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.

Kaye WH, Berrettini W, Gwirtsman H, George DT.

Arch Gen Psychiatry. 1990 Jun;47(6):548-56.

PMID:
2350207
15.

CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.

Kaye WH, Rubinow D, Gwirtsman HE, George DT, Jimerson DC, Gold PW.

Psychoneuroendocrinology. 1988;13(3):265-72.

PMID:
2900533
16.

Neurobiology of anorexia and bulimia nervosa.

Kaye W.

Physiol Behav. 2008 Apr 22;94(1):121-35. doi: 10.1016/j.physbeh.2007.11.037. Epub 2007 Nov 29. Review.

17.

A ghrelin gene variant may predict crossover rate from restricting-type anorexia nervosa to other phenotypes of eating disorders: a retrospective survival analysis.

Ando T, Komaki G, Nishimura H, Naruo T, Okabe K, Kawai K, Takii M, Oka T, Kodama N, Nakamoto C, Ishikawa T, Suzuki-Hotta M, Minatozaki K, Yamaguchi C, Nishizono-Maher A, Kono M, Kajiwara S, Suematsu H, Tomita Y, Ebana S, Okamoto Y, Nagata K, Nakai Y, Koide M, Kobayashi N, Kurokawa N, Nagata T, Kiriike N, Takenaka Y, Nagamine K, Ookuma K, Murata S; Japanese Genetic Research Group for Eating Disorders.

Psychiatr Genet. 2010 Aug;20(4):153-9. doi: 10.1097/YPG.0b013e32833a1f0e.

PMID:
20421852
18.

Eating-related concerns, mood, and personality traits in recovered bulimia nervosa subjects: a replication study.

Stein D, Kaye WH, Matsunaga H, Orbach I, Har-Even D, Frank G, McConaha CW, Rao R.

Int J Eat Disord. 2002 Sep;32(2):225-9.

PMID:
12210666
19.
20.

Cerebrospinal fluid peptide YY immunoreactivity in eating disorders.

Berrettini WH, Kaye WH, Gwirtsman H, Allbright A.

Neuropsychobiology. 1988;19(3):121-4.

PMID:
3200408

Supplemental Content

Support Center